News

Filter

126 to 135 of 95979 results

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Tentative FDA approval for Lilly and Boehringer Ingelheim's Basaglar

Tentative FDA approval for Lilly and Boehringer Ingelheim's Basaglar

19-08-2014

The US Food and Drug Administration yesterday granted tentative approval for Basaglar (insulin glargine…

AbasriaBasaglarBiosimilarsBoehringer IngelheimDiabetesEli LillyInsulin Glargine [rDNA origin] InjectionLantusPharmaceuticalRegulationUSA

Pfizer files palbociclib NDA with FDA for breast cancer

Pfizer files palbociclib NDA with FDA for breast cancer

19-08-2014

US pharma giant Pfizer says it has completed the submission of a New Drug Application to the US Food…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Further positive Ph III results for Amgen’s AMG 416 in secondary hyperparathyroidism

Further positive Ph III results for Amgen’s AMG 416 in secondary hyperparathyroidism

19-08-2014

USA-based Amgen has released positive data from a second placebo-controlled Phase III study evaluating…

AMG 416AmgenBiotechnologyClinical researchHemodialysisNephrology and HepatologyResearchUSA

Provectus opens negotiations on licensing PV-10 in China

Provectus opens negotiations on licensing PV-10 in China

19-08-2014

US developmental stage company Provectus Biopharmaceuticals has entered into a memorandum of understanding…

Breast cancerChinaLicensingMemorandum of understandingOncologyPharmaceuticalProvectus BiopharmaceuticalsPV-10Sinopharm

AstraZeneca reports positive results from Phase III antibiotic study

AstraZeneca reports positive results from Phase III antibiotic study

19-08-2014

Anglo-Swedish drug major AstraZeneca has achieved positive results from the pivotal Phase III studies…

ActavisAntibiotics and Infectious diseasesAstraZenecaavibactamCeftazidimeComplicated intra-abdominal infectionsForest LaboratoriesMedicinePharmaceuticalResearchSerious bacterial infectionsUK

Novartis makes investment in stem cell company Gamida Cell with option agreement

Novartis makes investment in stem cell company Gamida Cell with option agreement

19-08-2014

Swiss drug major Novartis has signed an investment and option agreement with Israeli stem cell specialist…

BiotechnologyFinancialGamida CellHematologyIsraelNovartisStem cell specialistSwitzerland

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

19-08-2014

Dutch biotech company Pharming Group says that, through the acquisition of certain assets of Transgenic…

BiotechnologyMergers & AcquisitionsNetherlandsPharmingPharming Group NVTreatment of Pompe’s disease

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

19-08-2014

Anglo-Swedish drug major AstraZeneca has received confirmation from the US Department of Justice that…

AstraZenecaBrilintaBrilintaCardio-vascularLegalPharmaceuticalUKUSA

126 to 135 of 95979 results

Back to top